Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 529–552 of 1,279 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Infection Prophylaxis Clear all

Conditions: Substance Use, HIV/AIDS
Interventions: TIPS app, Trauma Focused-Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 12 Years to 18 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Mentally Ill Persons, Substance Abuse, HIV Infections
Interventions: PATH; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 238 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections, Sexually Transmitted Infection
Interventions: PrEPwise, Usual care; Behavioral · Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: HIV Infections
Interventions: MVA-CMDR, Placebo; Biological
Lead sponsor: U.S. Army Medical Research and Development Command; Federal
Eligibility: 18 Years to 40 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Bacillus Anthracis (Anthrax)
Interventions: BioThrax®; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 328 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 4
States / cities: Atlanta, Georgia • Cincinnati, Ohio • Houston, Texas + 1 more

Conditions: Adolescent Behavior, HIV/AIDS, PrEP
Interventions: Telehealth Coaching; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 15 Years to 21 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Post Operative Surgical Site Infection
Interventions: Treatment group, Control group; Drug
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1,660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 41
States / cities: Birmingham, Alabama • Los Angeles, California • Redwood City, California + 35 more

Conditions: COVID-19
Interventions: HB-adMSCs, Placebos; Biological · Other
Lead sponsor: Hope Biosciences Research Foundation; Industry
Eligibility: Not listed
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Sugar Land, Texas

Conditions: Infection Prevention
Interventions: Antibiotic-impregnated Catheters (M/R), Non-impregnated Catheters (C/S); Device
Lead sponsor: Indiana University; Other
Eligibility: Up to 17 Years
Enrollment: 326 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: HIV Infections
Interventions: Affect Management, General Health Promotion; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 12 Years to 14 Years
Enrollment: 420 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Vaccinia
Interventions: Vaccine: SIGA-246; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Anthrax
Interventions: BioThrax, Ciprofloxacin; Biological · Drug
Lead sponsor: Emergent BioSolutions; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 154 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 3
States / cities: Kansas City, Missouri • Omaha, Nebraska • Dallas, Texas

Conditions: Teen Pregnancy, Pregnancy in Adolescence, Teen Pregnancy Prevention, Pregnancy Prevention, Sexually Transmitted Diseases
Interventions: Future Foundation 2.0 PREIS Program; Behavioral
Lead sponsor: Metis Associates, Inc.; Industry
Eligibility: 10 Years to 14 Years
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: East Point, Georgia

Conditions: Ventilator Associated Pneumonia (VAP), Other Infections, Antibiotic-Associated Diarrhea, C-Difficile, Duration of Mechanical Ventilation, Length of ICU Stay, Length of Hospital Stay, ICU and Hospital Mortality
Interventions: L. rhamnosus GG - Probiotic, Placebo - Microcrystalline Cellulose; Drug · Other
Lead sponsor: McMaster University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Rochester, Minnesota • St Louis, Missouri

Conditions: HIV Infections
Interventions: Get Connected, HIV Test Locator; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 15 Years to 24 Years · Male only
Enrollment: 285 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 3
States / cities: Atlanta, Georgia • Philadelphia, Pennsylvania • Houston, Texas

Conditions: Infection
Interventions: Ciprofloxacin, trimethoprim-sulfamethoxazole, cefuroxime, ceftriaxone, gentamicin, amikacin, aztreonam, imipenem; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 30 Years to 90 Years · Male only
Enrollment: 563 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Sexually Transmitted Infection
Interventions: Doxycycline; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 59 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Urinary Retention, Urinary Tract Infections
Interventions: Tamsulosin, Placebo; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Influenza, Virus Diseases
Interventions: H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca); Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 49 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: HIV, Sexually Transmitted Diseases, Pre-exposure Prophylaxis, Risk Reduction
Interventions: MyChoices; Behavioral
Lead sponsor: Fenway Community Health; Other
Eligibility: 15 Years to 24 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Boston, Massachusetts • The Bronx, New York

Conditions: Dengue Fever
Interventions: rDEN4delta30-200,201, Placebo; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: SARS CoV 2 Infection
Interventions: Sotrovimab; Drug
Lead sponsor: Sophia Koo, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Trichomonas Vaginalis, Urethritis
Interventions: Patient-delivered partner treatment, Booklet-enhanced partner referral; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 16 Years to 44 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 2
States / cities: New Orleans, Louisiana

Conditions: Out-Of-Hospital Cardiac Arrest, Pneumonia
Interventions: Standard of care without prophylaxis, Antibiotic prophylaxis; Drug
Lead sponsor: David J. Gagnon; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Portland, Maine

Search by objective public record fields.

Trauma Informed Prevention for Substance Use and Risky Sex

HIV Prevention Among Substance Abusing SMI

PrEPwise Pilot Among Black Women in Eastern Virginia

Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Evaluating The Acceptability and Uptake of Pre-Exposure Prophylaxis (PrEP) for Adolescent Women in The Deep South

Topical Antibiotic Therapy to Reduce Infection After Operative Treatment of Fractures at High Risk of Infection: TOBRA

A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.

Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children

Affect Management for Early Adolescents

SIGA-246 to Treat Smallpox

Ciprofloxacin BioThrax Co-Administration Study

Future Foundation 2.0 Personal Responsibility Education Innovative Strategies (PREIS) Program

Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical Trial

Get Connected Efficacy Trial

Antibiotic Prophylaxis for Transrectal Prostate Biopsy

Daily Doxycycline to Inform Sexually Transmitted Infection Prophylaxis Regimens

Prevention of Post-operative Urinary Retention

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Mobile-Based Application "MyChoices"

Safety of and Immune Response to a Dengue Virus Vaccine (rDEN4delta30-200,201) in Healthy Adults

A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

Study to Improve Partner Services for STD Prevention

Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)